ENGLISH ARON R. sold 84.0% of their position (1.39M shares) of LIFECORE BIOMEDICAL, INC. \DE\ on the open market
Open‑market sale worth $9.13M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/28/2025ACC: 0000950170-25-078524
10% Owner
Since May 2025
-1.39M
Net shares
Net seller
$9.13M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.39M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−96.14K
Price / share
$6.75
Trade value
$649.39K
% of position
5.8%
5/23/2025
1.65M→1.55M
Common Stock
Indirect
Shares
−1.14M
Price / share
$6.50
Trade value
$7.41M
% of position
73.3%
5/27/2025
1.55M→414.60K
Common Stock
Indirect
Shares
−150.42K
Price / share
$7.12
Trade value
$1.07M
% of position
36.3%
5/28/2025
414.60K→264.18K
Total
Net shares
−1.39M
Net value
-$9.13M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/23/2025 | S · Sale | −96.14K | $6.75 | $649.39K | 5.8% | 1.65M | 1.55M |
| Common Stock Indirect | 5/27/2025 | S · Sale | −1.14M | $6.50 | $7.41M | 73.3% | 1.55M | 414.60K |
| Common Stock Indirect | 5/28/2025 | S · Sale | −150.42K | $7.12 | $1.07M | 36.3% | 414.60K | 264.18K |
| Total | −1.39M | -$9.13M | ||||||
Derivative Transactions0
No derivative transactions reported